245 related articles for article (PubMed ID: 15358665)
1. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.
Fernández-Avilés F; San Román JA; García-Frade J; Fernández ME; Peñarrubia MJ; de la Fuente L; Gómez-Bueno M; Cantalapiedra A; Fernández J; Gutierrez O; Sánchez PL; Hernández C; Sanz R; García-Sancho J; Sánchez A
Circ Res; 2004 Oct; 95(7):742-8. PubMed ID: 15358665
[TBL] [Abstract][Full Text] [Related]
2. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
Drexler H; Meyer GP; Wollert KC
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
[TBL] [Abstract][Full Text] [Related]
3. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.
Ruan W; Pan CZ; Huang GQ; Li YL; Ge JB; Shu XH
Chin Med J (Engl); 2005 Jul; 118(14):1175-81. PubMed ID: 16117862
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.
Kajstura J; Rota M; Whang B; Cascapera S; Hosoda T; Bearzi C; Nurzynska D; Kasahara H; Zias E; Bonafé M; Nadal-Ginard B; Torella D; Nascimbene A; Quaini F; Urbanek K; Leri A; Anversa P
Circ Res; 2005 Jan; 96(1):127-37. PubMed ID: 15569828
[TBL] [Abstract][Full Text] [Related]
5. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
8. Effect of infarct severity on regional and global left ventricular remodeling in patients with successfully reperfused ST segment elevation myocardial infarction.
Symons R; Masci PG; Goetschalckx K; Doulaptsis K; Janssens S; Bogaert J
Radiology; 2015 Jan; 274(1):93-102. PubMed ID: 25207466
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction.
Obradović S; Rusović S; Balint B; Ristić-Andelkov A; Romanović R; Baskot B; Vojvodić D; Gligić B
Vojnosanit Pregl; 2004; 61(5):519-29. PubMed ID: 15551805
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
[TBL] [Abstract][Full Text] [Related]
11. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.
Wang X; Hu Q; Nakamura Y; Lee J; Zhang G; From AH; Zhang J
Stem Cells; 2006 Jul; 24(7):1779-88. PubMed ID: 16614004
[TBL] [Abstract][Full Text] [Related]
12. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium.
Smits AM; van Laake LW; den Ouden K; Schreurs C; Szuhai K; van Echteld CJ; Mummery CL; Doevendans PA; Goumans MJ
Cardiovasc Res; 2009 Aug; 83(3):527-35. PubMed ID: 19429921
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Assmus B; Schächinger V; Teupe C; Britten M; Lehmann R; Döbert N; Grünwald F; Aicher A; Urbich C; Martin H; Hoelzer D; Dimmeler S; Zeiher AM
Circulation; 2002 Dec; 106(24):3009-17. PubMed ID: 12473544
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes.
Xaymardan M; Tang L; Zagreda L; Pallante B; Zheng J; Chazen JL; Chin A; Duignan I; Nahirney P; Rafii S; Mikawa T; Edelberg JM
Circ Res; 2004 Mar; 94(5):E39-45. PubMed ID: 14963008
[TBL] [Abstract][Full Text] [Related]
16. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
[TBL] [Abstract][Full Text] [Related]
17. [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction].
Strauer BE; Brehm M; Zeus T; Gattermann N; Hernandez A; Sorg RV; Kögler G; Wernet P
Dtsch Med Wochenschr; 2001 Aug; 126(34-35):932-8. PubMed ID: 11523014
[TBL] [Abstract][Full Text] [Related]
18. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
[TBL] [Abstract][Full Text] [Related]
19. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
Traverse JH; Henry TD; Moye' LA
Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
[TBL] [Abstract][Full Text] [Related]
20. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
